APA (7th ed.) Citation

PL, H., HT, K., CH, H., HT, H., WC, C., RY, H., & JJ, Y. (2023). Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity. Journal of translational medicine, 21(1), 550. https://doi.org/10.1186/s12967-023-04410-1

Chicago Style (17th ed.) Citation

PL, Huang, Kan HT, Hsu CH, Hsieh HT, Cheng WC, Huang RY, and You JJ. "Correction: A Bispecific Antibody AP203 Targeting PD-L1 and CD137 Exerts Potent Antitumor Activity Without Toxicity." Journal of Translational Medicine 21, no. 1 (2023): 550. https://doi.org/10.1186/s12967-023-04410-1.

MLA (9th ed.) Citation

PL, Huang, et al. "Correction: A Bispecific Antibody AP203 Targeting PD-L1 and CD137 Exerts Potent Antitumor Activity Without Toxicity." Journal of Translational Medicine, vol. 21, no. 1, 2023, p. 550, https://doi.org/10.1186/s12967-023-04410-1.